Works by Hosoya, Tatsuo


Results: 150
    1
    2
    3
    4
    5

    Serum soluble α-Klotho in hemodialysis patients.

    Published in:
    Clinical Nephrology, 2012, v. 77, n. 5, p. 347, doi. 10.5414/CN107204
    By:
    • Yokoyama, Keitaro;
    • Imura, Akihiko;
    • Ohkido, Ichiro;
    • Maruyama, Yukio;
    • Yamazaki, Yuji;
    • Hasegawa, Hisashi;
    • Urae, Jun;
    • Sekino, Hiroshi;
    • Nabeshima, Yo-ichi;
    • Hosoya, Tatsuo
    Publication type:
    Article
    6
    7
    8
    9
    10
    11

    Keap1 inhibition attenuates glomerulosclerosis.

    Published in:
    Nephrology Dialysis Transplantation, 2014, v. 29, n. 4, p. 783, doi. 10.1093/ndt/gfu002
    By:
    • Miyazaki, Yoichi;
    • Shimizu, Akihiro;
    • Pastan, Ira;
    • Taguchi, Keiko;
    • Naganuma, Eriko;
    • Suzuki, Takafumi;
    • Hosoya, Tatsuo;
    • Yokoo, Takashi;
    • Saito, Akihiko;
    • Miyata, Toshio;
    • Yamamoto, Masayuki;
    • Matsusaka, Taiji
    Publication type:
    Article
    12
    13
    14
    15
    16
    17
    18
    19
    20

    Cyclosporine and Entrapment Neuropathy.

    Published in:
    Acta Haematologica, 1998, v. 100, n. 3, p. 159, doi. 10.1159/000040893
    By:
    • Kaito, Ken;
    • Kobayashi, Masayuki;
    • Otsubo, Hiroko;
    • Ogasawara, Yoji;
    • Sekita, Toru;
    • Shimada, Takaki;
    • Hosoya, Tatsuo
    Publication type:
    Article
    21
    22

    Antiproteinuric effect of olmesartan in patients with IgA nephropathy.

    Published in:
    Journal of Nephrology (JNonline), 2009, v. 22, n. 2, p. 224
    By:
    • Tomino, Yasuhiko;
    • Kawamura, Tetsuya;
    • Kimura, Kenjiro;
    • Endoh, Masayuki;
    • Hosoya, Tatsuo;
    • Horikoshi, Satoshi;
    • Utsunomiya, Yasunori;
    • Yasuda, Takashi;
    • Toyoda, Masao;
    • Tsuge, Toshinao;
    • Kaneko, Kotaro
    Publication type:
    Article
    23
    24
    25
    26

    The effect of febuxostat to prevent a further reduction in renal function of patients with hyperuricemia who have never had gout and are complicated by chronic kidney disease stage 3: study protocol for a multicenter randomized controlled study.

    Published in:
    Trials, 2014, v. 15, n. 1, p. 1, doi. 10.1186/1745-6215-15-26
    By:
    • Tatsuo Hosoya;
    • Kenjiro Kimura;
    • Sadayoshi Itoh;
    • Masaaki Inaba;
    • Shunya Uchida;
    • Yasuhiko Tomino;
    • Hirofumi Makino;
    • Seiichi Matsuo;
    • Tetsuya Yamamoto;
    • Iwao Ohno;
    • Yugo Shibagaki;
    • Satoshi Iimuro;
    • Naohiko Imai;
    • Masanari Kuwabara;
    • Hiroshi Hayakawa
    Publication type:
    Article
    27

    The effect of febuxostat to prevent a further reduction in renal function of patients with hyperuricemia who have never had gout and are complicated by chronic kidney disease stage 3: study protocol for a multicenter randomized controlled study.

    Published in:
    2014
    By:
    • Hosoya, Tatsuo;
    • Kimura, Kenjiro;
    • Itoh, Sadayoshi;
    • Inaba, Masaaki;
    • Uchida, Shunya;
    • Tomino, Yasuhiko;
    • Makino, Hirofumi;
    • Matsuo, Seiichi;
    • Yamamoto, Tetsuya;
    • Ohno, Iwao;
    • Shibagaki, Yugo;
    • Iimuro, Satoshi;
    • Imai, Naohiko;
    • Kuwabara, Masanari;
    • Hayakawa, Hiroshi
    Publication type:
    journal article
    28
    29
    30
    31
    32
    33
    34

    Peritoneal clearance and transport of methylglyoxal.

    Published in:
    Nephrology Dialysis Transplantation, 2011, v. 26, n. 2, p. 753, doi. 10.1093/ndt/gfq698
    By:
    • Terawaki, Hiroyuki;
    • Nakao, Masatsugu;
    • Nakayama, Keisuke;
    • Nakayama, Masaaki;
    • Kimura, Ai;
    • Takane, Koki;
    • Mitome, Jun;
    • Hamaguchi, Akihiko;
    • Ogura, Makoto;
    • Yokoyama, Keitaro;
    • Ito, Sadayoshi;
    • Hosoya, Tatsuo
    Publication type:
    Article
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50